Fundraising Fox
Sonavi Labs
Baltimore, US · Founded 2017 · Delaware corporation · 4 known investors
Find your way into Sonavi Labs
Sign up to see every warm intro you have to Sonavi Labs
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sonavi Labs team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sonavi Labs develops diagnostic technology to detect respiratory infections, originating from a Gates Foundation challenge to reduce pediatric mortality. The company focuses on affordable, accessible tools designed to enable rapid diagnosis across different education levels and socioeconomic backgrounds.
Founders & leadership
Sonavi Labs was founded in 2017 by Ellington West and Ian McLane.
IM
Ian McLaneCo-founder30 Under 30 2022
JM
Jaishree McLaneExecutive
BD
Brandon Dottin-HaleyExecutive
Board
IB
Ilene Busch-VishniacBoard director
LW
Leslie WiseBoard director
Investors · 4
__Twitter.png)
Reported raises · per SEC filings
Form D private placements$769.7K disclosed across 3 of 6 rounds · 2018–2021
▶$5MofferedMay 2021 · Other TechnologyRule 506(b)
▶$5MofferedMay 2021 · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Ellington WestExecutive Officer, Director, Promoter
- Ian McLaneExecutive Officer, Director
- Ilene Busch-VishniacExecutive Officer, Director, Promoter
- Jaishree McLaneExecutive Officer, Director, Promoter
- Brandon Dottin-HaleyExecutive Officer, Director, Promoter
- Leslie WiseDirector
- Offering amount
- $5M
- Minimum investment
- $20K
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$2MofferedJun 2020 · Other TechnologyRule 506(b)
▶$2MofferedJun 2020 · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Ilene Busch-VishniacExecutive Officer, Director, Promoter
- Jaishree McLaneExecutive Officer, Director, Promoter
- Brandon Dottin-HaleyDirector
- Ellington WestExecutive Officer, Director, Promoter
- Ian McLaneExecutive Officer, Director
- Offering amount
- $2M
- Minimum investment
- $20K
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$500KofferedSep 2019 · Other TechnologyRule 506(b)
▶$500KofferedSep 2019 · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jaishree McLaneExecutive Officer
- Ellington WestExecutive Officer, Director, Promoter
- Ian McLaneExecutive Officer, Director
- Ilene Busch-VishniacExecutive Officer, Director, Promoter
- Offering amount
- $500K
- Minimum investment
- $20K
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$581KraisedMay 2019 · 21 investors · Other TechnologyRule 506(b)
▶$581KraisedMay 2019 · 21 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Ellington WestExecutive Officer, Director
- Illene Busch-VishniacExecutive Officer, Director
- Ian McLaneExecutive Officer, Director
- Jaishree McLaneExecutive Officer
- Amount sold
- $581K
- Minimum investment
- $10K
- Proceeds to insiders
- $200K
- First sale
- May 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$163.7KraisedDec 2018 · 4 investors · Other TechnologyRule 506(b)
▶$163.7KraisedDec 2018 · 4 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Illene Busch-VishniacExecutive Officer
- Dimitra EmmanouilidouDirector
- Arthur WardExecutive Officer
- Jaishree McLaneExecutive Officer
- Ian McLaneExecutive Officer, Director
- Ellington WestExecutive Officer, Director
- Amount sold
- $163.7K
- Minimum investment
- $10K
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$25KraisedApr 2018 · 1 investors · Other TechnologyRule 506(b)
▶$25KraisedApr 2018 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Ellington WestExecutive Officer
- Dimitra EmmanouilidouDirector
- Ian McLaneDirector
- Jaishree McLaneExecutive Officer
- Arthur WardExecutive Officer
- Offering amount
- $25K
- Amount sold
- $25K
- Minimum investment
- $10K
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2022 | $1.1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2020 | $236.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $222.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Sonavi Labs do?
- Sonavi Labs develops diagnostic technology to detect respiratory infections, originating from a Gates Foundation challenge to reduce pediatric mortality. The company focuses on affordable, accessible tools designed to enable rapid diagnosis across different education levels and socioeconomic backgrounds.
- Who founded Sonavi Labs?
- Sonavi Labs was founded by Ellington West, Ian McLane in 2017.
- Who are Sonavi Labs's investors?
- Sonavi Labs's investors include Catalytic Impact Foundation, Gaingels, Sand Hill Angels, xfactor ventures.
- How much funding has Sonavi Labs raised?
- Sonavi Labs has disclosed $769.7K raised across 3 of its 6 known rounds.
- Where is Sonavi Labs headquartered?
- Sonavi Labs is headquartered in Baltimore, US.